Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06695585 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 19, 2024 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The purpose of our study is to evaluate the efficacy and safety of different volumes of bladder-numbing medication for pain relief at the time of office bladder Botox injections. This is a randomized prospective, double-blind superiority trial comparing 200 ml 2% lidocaine versus 30 ml 2% lidocaine for office Botox injections.
Trial Details
NCT Number NCT06695585
Lead Sponsor University of Louisville
Conditions
(from sponsor)		 Overactive Bladder, Overactive Bladder Syndrome, Urinary Urgency, Urinary Frequency, Urge Incontinence, Neurogenic Bladder
Related terms Urinary Bladder, Neurogenic, Urinary Bladder, Overactive, Urinary Incontinence, Urge
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov